BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Choi C, Yoo GS, Cho WK, Park HC. Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma. World J Gastroenterol 2019; 25(20): 2416-2429 [PMID: 31171886 DOI: 10.3748/wjg.v25.i20.2416]
URL: https://www.wjgnet.com/1007-9327/full/v25/i20/2416.htm
Number Citing Articles
1
Yan Xia, Xin Lin, Yangyang Cheng, Huimin Xu, Jingya Zeng, Wanlin Xie, Mingzhu Wang, Yihua Sun. Characterization of Platelet Function-Related Gene Predicting Survival and Immunotherapy Efficacy in Gastric CancerFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.938796
2
Alexia Paturel, Janet Hall, Isabelle Chemin. Poly(ADP-Ribose) Polymerase Inhibition as a Promising Approach for Hepatocellular Carcinoma TherapyCancers 2022; 14(15): 3806 doi: 10.3390/cancers14153806
3
David Tai, Su Pin Choo, Valerie Chew. Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential BiomarkersCancers 2019; 11(12): 1926 doi: 10.3390/cancers11121926
4
Sajad Shafiekhani, Nematollah Gheibi, Azam Janati Esfahani. Combination of anti-PD-L1 and radiotherapy in hepatocellular carcinoma: a mathematical model with uncertain parametersSIMULATION 2023; 99(4): 313 doi: 10.1177/00375497221133846
5
Min ren, Bei Fan, Guangcai Cao, Rongrong Zong, Liaoliao Feng, Huiru Sun. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancerBMC Genomics 2023; 24(1) doi: 10.1186/s12864-023-09876-3
6
Sunmin Park, Won Sup Yoon, Mi Hee Jang, Chai Hong Rim. Clinical efficacy of external beam radiotherapy complementing incomplete transarterial chemoembolization for hepatocellular carcinomaInternational Journal of Radiation Biology 2020; 96(12): 1541 doi: 10.1080/09553002.2020.1830316
7
Ann-Lii Cheng, Chiun Hsu, Stephen L. Chan, Su-Pin Choo, Masatoshi Kudo. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinomaJournal of Hepatology 2020; 72(2): 307 doi: 10.1016/j.jhep.2019.09.025
8
Peng Zeng, Duo Shen, Wenbin Shu, Shudan Min, Min Shu, Xijuan Yao, Yong Wang, Rong Chen. Identification of a novel peptide targeting TIGIT to evaluate immunomodulation of 125I seed brachytherapy in HCC by near-infrared fluorescenceFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1143266
9
Sung-Won Shin, Kyungmi Yang, Miso Lee, Jiyoung Moon, Arang Son, Yeeun Kim, Suha Choi, Do-hyung Kim, Changhoon Choi, Nohyun Lee, Hee Chul Park. Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor MicroenvironmentsInternational Journal of Molecular Sciences 2021; 22(5): 2637 doi: 10.3390/ijms22052637
10
Luis A. Pérez-Romasanta, Elisabet González-Del Portillo, Ana Rodríguez-Gutiérrez, Ángela Matías-Pérez. Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy CombinationCancers 2021; 13(2): 192 doi: 10.3390/cancers13020192
11
Kyoung‐Jin Kim, Hye Won Lee, Jinsil Seong. Combination therapy with anti‐T‐cell immunoglobulin and mucin‐domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2021; 36(5): 1357 doi: 10.1111/jgh.15319
12
Ning Sun, Jialin Zhang, Baifeng Li, Ailin Li, Mutian Lv, Chengshuo Zhang. Favorable response to multimodal treatment in hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus and left adrenal gland metastasisMedicine 2021; 100(49): e27987 doi: 10.1097/MD.0000000000027987
13
Thomas Helmberger. The evolution of interventional oncology in the 21st centuryThe British Journal of Radiology 2020; 93(1113) doi: 10.1259/bjr.20200112
14
Hye Won Lee, Kyung Joo Cho, Jun Yong Park. Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?Immune Network 2020; 20(1) doi: 10.4110/in.2020.20.e11
15
Fang Fang, Bin Qiu, Peng Zhen, Junjie Wang. Hypofractionated Radiotherapy for Palliation of Main Portal Vein Tumor ThrombosisFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.882272
16
Han Ah Lee, Chai Hong Rim. Efficacy of Local Treatments for Hepatocellular Carcinoma Involving the Inferior Vena Cava and/or Right AtriumJournal of Hepatocellular Carcinoma 2020; : 435 doi: 10.2147/JHC.S285357
17
Jianing Ma, Yuning Xin, Qiang Wang, Lijuan Ding. Roles of cGAS-STING Pathway in Radiotherapy Combined with Immunotherapy for Hepatocellular CarcinomaMolecular Cancer Therapeutics 2024; 23(4): 447 doi: 10.1158/1535-7163.MCT-23-0373
18
Heather Nesbitt, Keiran Logan, Keith Thomas, Bridgeen Callan, Jinhui Gao, Thomas McKaig, Mark Taylor, Mark Love, Eleanor Stride, Anthony P. McHale, John F. Callan. Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancerCancer Letters 2021; 517: 88 doi: 10.1016/j.canlet.2021.06.003
19
Kyungmi Yang, Changhoon Choi, Hayeong Cho, Won-Gyun Ahn, Shin-Yeong Kim, Sung-Won Shin, Yeeun Kim, Taekyu Jang, Nohyun Lee, Hee Chul Park. Antigen-Capturing Mesoporous Silica Nanoparticles Enhance the Radiation-Induced Abscopal Effect in Murine Hepatocellular Carcinoma Hepa1-6 ModelsPharmaceutics 2021; 13(11): 1811 doi: 10.3390/pharmaceutics13111811
20
Liang-Cheng Chen, Hon-Yi Lin, Shih-Kai Hung, Wen-Yen Chiou, Moon-Sing Lee. Role of modern radiotherapy in managing patients with hepatocellular carcinomaWorld Journal of Gastroenterology 2021; 27(20): 2434-2457 doi: 10.3748/wjg.v27.i20.2434
21
Francesca Romana Ponziani, Francesco Santopaolo, Alessandro Posa, Maurizio Pompili, Alessandro Tanzilli, Marta Maestri, Maria Pallozzi, Francesca Ibba, Riccardo Manfredi, Antonio Gasbarrini, Roberto Iezzi. SIRT in 2025CardioVascular and Interventional Radiology 2022; 45(11): 1622 doi: 10.1007/s00270-022-03228-6
22
Hailong Sheng, Yan Huang, Yazhi Xiao, Zhenru Zhu, Mengying Shen, Peitao Zhou, Zeqin Guo, Jian Wang, Hui Wang, Wencong Dai, Wanjun Zhang, Jingyuan Sun, Chuanhui Cao. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinomaJournal for ImmunoTherapy of Cancer 2020; 8(1): e000340 doi: 10.1136/jitc-2019-000340
23
Jun Won Kim, Ik Jae Lee. Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinomaClinical and Molecular Hepatology 2021; 27(1): 103 doi: 10.3350/cmh.2020.0297
24
Dexi Zhou, Jiajie Luan, Cheng Huang, Jun Li. Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?Gut and Liver 2021; 15(4): 500 doi: 10.5009/gnl20223
25
Chun-Chia Cheng, Ai-Sheng Ho, Cheng-Liang Peng, Jungshan Chang, Zong-Lin Sie, Chih-Liang Wang, Yi-Li Chen, Cheng-Yi Chen. Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8+ T cell activation to eradicate hepatocellular carcinomaInternational Immunopharmacology 2022; 112: 109110 doi: 10.1016/j.intimp.2022.109110
26
Yuting Qian, Long Gong, Su Li, Kun Mao, Xianming Li, Guixiang Liao. Case Report: Radiotherapy Plus Immunotherapy and Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma With a Right Atrium and Inferior Vena Cava Tumor ThrombusFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.879454
27
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park. Current role of proton beam therapy in patients with hepatocellular carcinomaInternational Journal of Gastrointestinal Intervention 2021; 10(4): 175 doi: 10.18528/ijgii210043
28
Zhihuai Wang, Adeel Ur Rehman, Xihu Qin, Chunfu Zhu, Siyuan Wu, Ihtisham Bukhari. PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular CarcinomaDisease Markers 2022; 2022: 1 doi: 10.1155/2022/7545666
29
Pil Soo Sung. Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinomaClinical and Molecular Hepatology 2022; 28(3): 333 doi: 10.3350/cmh.2021.0308
30
Qingqing Xie, Pengfei Zhang, Yuanyuan Wang, Wuxuan Mei, Changchun Zeng. Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunitiesFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.958720
31
Edo Kon, Itai Benhar. Immune checkpoint inhibitor combinations: Current efforts and important aspects for successDrug Resistance Updates 2019; 45: 13 doi: 10.1016/j.drup.2019.07.004
32
Yasuteru Kondo, Tatsuki Morosawa, Soichiro Minami, Yasuhito Tanaka. DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCCScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21472-1
33
Wonmo Sung, Theodore S. Hong, Mark C. Poznansky, Harald Paganetti, Clemens Grassberger. Mathematical Modeling to Simulate the Effect of Adding Radiation Therapy to Immunotherapy and Application to Hepatocellular CarcinomaInternational Journal of Radiation Oncology*Biology*Physics 2022; 112(4): 1055 doi: 10.1016/j.ijrobp.2021.11.008
34
Lingling Zhu, Xianzhe Yu, Li Wang, Jiewei Liu, Zihan Qu, Honge Zhang, Lu Li, Jiang Chen, Qinghua Zhou. Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challengesOncogenesis 2021; 10(7) doi: 10.1038/s41389-021-00335-w
35
Marta Maestri, Maria Pallozzi, Francesco Santopaolo, Lucia Cerrito, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Durvalumab: an investigational agent for unresectable hepatocellular carcinomaExpert Opinion on Investigational Drugs 2022; 31(4): 347 doi: 10.1080/13543784.2022.2033208
36
Bahman Abedi Kiasari, Arash Abbasi, Nadia Ghasemi Darestani, Nasim Adabi, Arsalan Moradian, Yalda Yazdani, Golsa Sadat Hosseini, Nasrin Gholami, Sheida Janati. Combination therapy with nivolumab (anti-PD-1 monoclonal antibody): A new era in tumor immunotherapyInternational Immunopharmacology 2022; 113: 109365 doi: 10.1016/j.intimp.2022.109365
37
Qian Xu, Huiya Ying, Chunming Xie, Rong Lin, Yangjin Huang, Ruhuang Zhu, Yuejuan Liao, Yuan Zeng, Fujun Yu. Characterization of neutrophil extracellular traps related gene pair for predicting prognosis in hepatocellular carcinomaThe Journal of Gene Medicine 2023; 25(11) doi: 10.1002/jgm.3551
38
Mahsa Pourhamzeh, Samieh Asadian, Hamed Mirzaei, Azita Minaei, Elahe Shahriari, Anastasia Shpichka, Hamidreza Aboulkheyr Es, Peter Timashev, Moustapha Hassan, Massoud Vosough. Novel antigens for targeted radioimmunotherapy in hepatocellular carcinomaMolecular and Cellular Biochemistry 2023; 478(1): 23 doi: 10.1007/s11010-022-04483-4
39
Jin Hee Park, Hee Yeon Kim, Anbok Lee, Young Kyeong Seo, Il-Hwan Kim, Eun-tae Park, Mi Seon Kang, Sung Jae Park, SaeGwang Park. Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1International Journal of Radiation Oncology*Biology*Physics 2021; 110(2): 510 doi: 10.1016/j.ijrobp.2020.12.031
40
Han Ah Lee, Sunmin Park, Yeon Seok Seo, Won Sup Yoon, In‐Soo Shin, Chai Hong Rim. Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: A systematic review and meta‐analysisJournal of Hepato-Biliary-Pancreatic Sciences 2021; 28(12): 1031 doi: 10.1002/jhbp.865
41
Antonio D'Alessio, Lorenza Rimassa, Alessio Cortellini, David James Pinato. PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future ProspectsJournal of Hepatocellular Carcinoma 2021; : 887 doi: 10.2147/JHC.S284440
42
Zhongxiang Du, Qi Zhang, Jie Yang. Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinomaMedicine 2023; 102(44): e35820 doi: 10.1097/MD.0000000000035820
43
Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo, Nicola Maurea. Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical ModelsJournal of Personalized Medicine 2020; 10(4): 179 doi: 10.3390/jpm10040179
44
Wenzhe Yin, Jun Xu, Chao Li, Xiankui Dai, Tong Wu, Jifeng Wen. Plantamajoside inhibits the proliferation and epithelial‐to‐mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia‐inducible factor‐1α‐dependent gene expressionCell Biology International 2020; 44(8): 1616 doi: 10.1002/cbin.11354
45
Changhoon Choi, Yeonwoo Cho, Arang Son, Sung-Won Shin, Yeon-Ju Lee, Hee Chul Park. Therapeutic Potential of (−)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge Agelas sp., as a Natural Radiosensitizer in Hepatocellular Carcinoma ModelsMarine Drugs 2020; 18(10): 500 doi: 10.3390/md18100500
46
Magalie Dosset, Elodie Lauret-Marie Joseph, Thaiz Rivera Vargas, Lionel Apetoh. Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint InhibitorsCells 2020; 9(7): 1727 doi: 10.3390/cells9071727
47
Nalee Kim, Jeong Il Yu, Hee Chul Park, Gyu Sang Yoo, Changhoon Choi, Jung Yong Hong, Ho Yeong Lim, Jeeyun Lee, Moon Seok Choi, Jung Eun Lee, Kyunga Kim. Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumabCancer Immunology, Immunotherapy 2021; 70(6): 1593 doi: 10.1007/s00262-020-02794-3
48
Chai Hong Rim, Hye Yoon Lee, Jung Sun Kim, Hakyoung Kim. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?International Journal of Radiation Biology 2021; 97(2): 111 doi: 10.1080/09553002.2021.1857453
49
Kaixiao Zhou, Yabo Jiang, Shuang Feng, Tingya Wang, Lili Wang, Jianping Cao, Yang Jiao. Combining radiation with immune checkpoint inhibitors therapy for HCC: From the alteration of the immune microenvironment by radiotherapyRadiation Medicine and Protection 2022; 3(4): 183 doi: 10.1016/j.radmp.2022.07.005
50
Chou-Yi Hsu, Mohammed Ahmed Mustafa, Ashwani Kumar, Atreyi Pramanik, Rajiv Sharma, Faraj Mohammed, Israa Abed Jawad, Imad Jasim Mohammed, Mohammad Y. Alshahrani, Noor Alhuda Mohammad Ali khalil, Ali Turki Shnishil, Munther Kadhim Abosaoda. Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticlesPathology - Research and Practice 2024; 256: 155266 doi: 10.1016/j.prp.2024.155266
51
Yvonne Chiung-Fang Hsu, Jason Chia-Hsien Cheng. Radiotherapy of Liver Cancer2021; : 325 doi: 10.1007/978-981-16-1815-4_23
52
Yi Dong Lin, Gui Shu Wu, Ming Yue Rao, Yu Hong Liu, Yun Wei Han, Jing Zhang, Jian Wen Zhang. Effect of cytokines on advanced hepatocellular carcinoma prognosis receiving radiotherapy and tislelizumab plus anlotinib: a single-center phase II clinical trialScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62523-z
53
Marine Valery, Baptiste Cervantes, Ramy Samaha, Maximiliano Gelli, Cristina Smolenschi, Alina Fuerea, Lambros Tselikas, Caroline Klotz-Prieux, Antoine Hollebecque, Valérie Boige, Michel Ducreux. Immunotherapy and Hepatocellular Cancer: Where Are We Now?Cancers 2022; 14(18): 4523 doi: 10.3390/cancers14184523
54
Mehmet Eşref ALKIŞ, Sefa YEŞİLBAŞ. Effect of electroporation on radiotherapy treatment in human hepatocellular carcinoma cellsJournal of Physical Chemistry and Functional Materials 2021; 4(2): 17 doi: 10.54565/jphcfum.1006281
55
Jinhong Jung, Ji Hyeon Joo, So Yeon Kim, Jin Hyoung Kim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Jin-hong Park, Sang Min Yoon. Radiologic Response as a Prognostic Factor in Advanced Hepatocellular Carcinoma with Macroscopic Vascular Invasion after Transarterial Chemoembolization and RadiotherapyLiver Cancer 2022; 11(2): 152 doi: 10.1159/000521227
56
Hao-Tian Liu, Meng-Jie Jiang, Zhu-Jian Deng, Le Li, Jian-Li Huang, Zhen-Xiu Liu, Le-Qun Li, Jian-Hong Zhong. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and ChallengesFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.737497
57
Yifei Dai, Weijie Qiang, Kequan Lin, Yu Gui, Xun Lan, Dong Wang. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinomaCancer Immunology, Immunotherapy 2021; 70(4): 967 doi: 10.1007/s00262-020-02743-0
58
Yan Xia, Xiaolu Wang, Jie Lin, Yuan Li, Lidan Dong, Xue Liang, Huai-Yu Wang, Xia Ding, Qi Wang. Gastric cancer fibroblasts affect the effect of immunotherapy and patient prognosis by inducing micro-vascular productionFrontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1375013
59
Fan Yang, Yan Zhao, Xiaohan Huang, Jin Zhang, Ting Zhang, Yaying Sun. A Cell Differentiation Trajectory-Related Signature for Predicting the Prognosis of Lung AdenocarcinomaGenetics Research 2022; 2022: 1 doi: 10.1155/2022/3483498
60
Abscopal effect: from a rare phenomenon to a new frontier in cancer therapyBiomarker Research 2024; 12(1) doi: 10.1186/s40364-024-00628-3
61
Gyu Sang Yoo, Won-Gyun Ahn, Shin-Yeong Kim, Wonseok Kang, Changhoon Choi, Hee Chul Park. Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model studyClinical and Molecular Hepatology 2021; 27(1): 144 doi: 10.3350/cmh.2020.0095
62
Li-Bin Xu, Zhen-Guo Zhao, Song-Feng Xu, Xin-Xin Zhang, Ting Liu, Chang-You Jing, Shu-Guang Zhang, Sheng-Ji Yu. The landscape of gene mutations and clinical significance of tumor mutation burden in patients with soft tissue sarcoma who underwent surgical resection and received conventional adjuvant therapyThe International Journal of Biological Markers 2020; 35(3): 14 doi: 10.1177/1724600820925095
63
Rixiong Wang, Nan Lin, Binbin Mao, Qing Wu. The efficacy of immune checkpoint inhibitors in advanced hepatocellular carcinoma: a meta-analysis based on 40 cohorts incorporating 3697 individualsJournal of Cancer Research and Clinical Oncology 2022; 148(5): 1195 doi: 10.1007/s00432-021-03716-1
64
Miao-Fen Chen, Ping-Tsung Chen, Ching-Chuan Hsieh, Chih-Chi Wang. Effect of Proton Therapy on Tumor Cell Killing and Immune Microenvironment for Hepatocellular CarcinomaCells 2023; 12(2): 332 doi: 10.3390/cells12020332